The demand for probiotic supplement items in Western Europe is expected to generate a revenue of around US$ 1,038.52 million in 2023. The regional demand for probiotic supplement derived from bacteria and fungi is poised to increase at a CAGR of 8.4% between 2023 and 2033. The total value of all probiotic supplement industries in Western Europe is expected to reach US$ 2,327.12 million by 2033.
Key Trends behind the Surge in Revenues by Probiotic Supplement Industry
| Attributes | Details |
|---|---|
| Industry Size of Western Europe in 2023 | US$ 1,038.52 million |
| Expected Industry Size of Western Europe by 2033 | US$ 2,327.12 million |
| Forecasted CAGR between 2023 to 2033 | 8.4% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The vast culinary diversity and cultural acceptance of fermented foods in different Western European countries promote the recognition of probiotics in pure form. The growing practice of consuming probiotics supplement in simple and concentrated supplies to improve digestive health presents lucrative growth opportunities in the region.
In many Western European countries, the demand for different types of nutraceuticals and functional foods has increased significantly in recent years. The consumption of probiotic supplement is growing more swiftly as consumers recognize it to provide both nutritional and functional benefits.
Probiotic supplement are easily accessible in Western Europe due to the extensive use of eCommerce which also favors manufacturers for better reach and product visibility. By taking advantage of targeted marketing tactics and direct-to-consumer sales made possible by eCommerce websites, pharmaceutical companies have been able to develop quickly in this sector.
A short comparative overview of the performance of probiotic supplement in different geographical regions is expected to broaden the understanding of industry opportunities. The higher popularity of probiotic supplement in Japan can be attributed to its typical demographic situation. On the contrary, the adoption scenario of probiotic supplement in Korea is yet to come up to universal levels.
Demand for Probiotic Supplement in Western Europe:
| Attributes | Demand for Probiotic Supplement in Western Europe |
|---|---|
| CAGR (2023 to 2033) | 8.4% |
| Valuation (2023) | US$ 1,038.52 million |
| Key Trend | High priority on all types of supplement products due to their greater emphasis on preventative healthcare and lifestyle. |
| Key Challenge | Probiotic supplement must fulfill strict safety and effectiveness requirements in order to comply with strict quality standards and laws in different countries. |
Popularity of Probiotic Supplement in Japan:
| Attributes | Popularity of Probiotic Supplement in Japan |
|---|---|
| CAGR (2023 to 2033) | 10.6% |
| Valuation (2023) | US$ 500.2 million |
| Key Trend | Probiotic supplement pills is rising with the growing percentage of elderly population in the country. |
| Key Challenge | The regulatory environment for any type of imported or locally produced dietary supplement is well-established and rigorous. |
Adoption Scenario of Probiotic Supplement in Korea:
| Attributes | Adoption Scenario of Probiotic Supplement in Korea |
|---|---|
| CAGR (2023 to 2033) | 11.6% |
| Valuation (2023) | US$ 241.03 million |
| Key Trend | Consumption of probiotic supplement pills is rising among Koreans as they are beginning to see gut health is essential to overall wellness. |
| Key Challenge | Greater inclination of Koreans for probiotic consumption in the form of food items like probiotic curd or yogurt. |
Principal Consultant
The demand for probiotic supplement among women in Western Europe is estimated to make up 43.6% of the industry share in 2023.
| Leading End User for Probiotic Supplement in Western Europe | Women |
|---|---|
| Total Value Share (2023) | 43.6% |
Probiotic pills, as useful and health-improving goods, fit well into women's busy schedules and changing dietary choices during pregnancy. However, the growing adoption of probiotic supplement to help with age-related digestive problems and boost immunity is expected to drive demand in other end user segments.
According to the analysis report, the share of lactobacillus in the overall industry could be 37.9% in 2023.
| Leading Bacteria Type for Probiotic Supplement in Western Europe | Lactobacillus |
|---|---|
| Total Value Share (2023) | 37.9% |
Several advantages of lactobacillus for gut health are backed by scientific research, which has led to a strong demand for them in Western European countries. Since consumers consider the prevention of digestive problems as an integral element of maintaining good health, this segment has consistently retained its dominance in the region.
| Key Countries in Western Europe | Value CAGR (2023 to 2033) |
|---|---|
| Netherlands | 9.1% |
| United Kingdom | 8.5% |
| France | 7.9% |
The demand for probiotic supplement in the Netherlands is forecasted to develop at 9.1% CAGR during the projected timeline.
The regulatory framework in place for the use of probiotic supplement by food and beverage industries fosters customer trust and is anticipated to promote and expedite the industry's growth. For example, the Netherlands Food and Drug Administration published guidelines in March 2021 to mention "probiotics" as essential data on food and supplement labels.
Over the forecasted years, the sales of probiotic supplement in the United Kingdom are projected to rise at 8.5% CAGR.
Producers of probiotic supplement in the United Kingdom have the advantage of a consumer base with a better understanding of the unique health benefits of their goods. Moreover, many probiotic supplement have established international supply chains that could play a pivotal role in the further growth of the industry.
The probiotic supplement industry in France is anticipated to expand at a 7.9% compound annual growth rate per year between 2023 and 2033.
In France, consumers are significantly influenced by the endorsements, testimonies, and suggestions of health experts regarding the use of supplement and functional foods. So, probiotic supplement suppliers in the country are using targeted advertisement and instructional initiatives to create an atmosphere that is favorable for their products.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The probiotic supplement industry in Western Europe is highly concentrated, with a few dominant companies including Nestle, BioGaia, and Sinbiotic holding a significant revenue share. In recent years, these leading players have further solidified their places by releasing consumer-oriented products in packaged form. On the other hand, smaller companies in this sector have prioritized probiotic research and innovations to serve a diverse clientele and enhance their brand recognition.
Recent Developments by Probiotic Supplement Industries in Western Europe
In May 2023, Roquette expanded the health and nutrition industry toward a more flexible, reliable, and consumer-focused future for probiotic supplement with the introduction of PEARLITOL® ProTec. This new excipient is a novel plant-based co-processed combination of mannitol and maize starch which stabilizes and extends the shelf life of active probiotics that are sensitive to moisture.
In August 2022, BioGaia Campany declared to add new bacterial strains to its product lineup, which it would be developing in partnership with its subsidiary MetaboGen. The two companies are also working together to construct a fermentation pilot facility in Eslöv to develop these novel strains through clinical trials.
| Attribute | Details |
|---|---|
| Estimated Industry Size in 2023 | US$ 1,038.52 million |
| Projected Industry Size by 2033 | US$ 2,327.12 million |
| Anticipated CAGR between 2023 to 2033 | 8.4% CAGR |
| Historical Analysis of Demand for Probiotic Supplement in Western Europe | 2018 to 2022 |
| Demand Forecast for Probiotic Supplement in Western Europe | 2023 to 2033 |
| Report Coverage | Industry Size, Industry Trends, Analysis of key factors influencing Probiotic Supplement Adoption in Western Europe, Insights on Global Players and their Industry Strategy in Western Europe, Ecosystem Analysis of Local and Regional Western Europe Manufacturers |
| Key Countries Analyzed while Studying Opportunities in Probiotic Supplement in Western Europe | Germany, Italy, France, Spain, United Kingdom, BENELUX, Rest of Western Europe |
| Key Companies Profiled | Alphanova (France); Altaïcare (France); Arkopharma (France); Arla Foods (Denmark); Atida Sweden (Sweden); BioGaia (Sweden); Danone (France); Dr. Willmar Schwabe (Germany); Embark Holdings (United Kingdom); Galderma (Switzerland); GlaxoSmithKline (United Kingdom); Herbapol (Poland); Hero Group (Spain); Holland & Barrett (United Kingdom); Innova Biosciences (Spain); Kerry Group (Ireland); Nestlé (Switzerland); New Nordic (Denmark); Nutraingredients (United Kingdom); Orkla Health (Norway); Pharma Nord (Denmark); Procter & Gamble (United States); Proderna (Belgium); Provita (Spain); Qiagen (Germany); Reckitt Benckiser (United Kingdom); Synbiotic International (United Kingdom); Valio (Finland); Vitabiotics (United Kingdom); Wessanen (Netherlands) |
The expected CAGR for the industry in Western Europe through 2033 is 8.4%.
The anticipated demand in Western Europe is likely to reach US$ 2,327.12 million by 2033.
The rising popularity of supplement in chewable form has impacted the regional sales.
Probiotic supplement manufacturers are emphasizing more on promotional activities.
Women are set to account for 43.6% of overall demand across Western Europe in 2023.
1. Executive Summary 1.1. Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Industry Analysis and Outlook 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (Tons) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Bacteria 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Bacteria, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Bacteria, 2023 to 2033 5.3.1. Lactobacillus 5.3.2. Streptococcus 5.3.3. Bifid bacterium 5.4. Y-o-Y Growth Trend Analysis By Bacteria, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Bacteria, 2023 to 2033 6. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Form 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Form, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Form, 2023 to 2033 6.3.1. Tablet 6.3.2. Capsules 6.3.3. Liquid 6.3.4. Powder Premixes 6.3.5. Gummies/Chewable 6.3.6. Lozenges 6.3.7. Liquid & Gels 6.4. Y-o-Y Growth Trend Analysis By Form, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Form, 2023 to 2033 7. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Function 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Function, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Function, 2023 to 2033 7.3.1. Immunity & Digestive Health 7.3.2. Urogenital Health 7.3.3. Vaginal Health 7.3.4. Urinary Tract Infections 7.3.5. Pregnancy 7.3.6. Weight Management 7.4. Y-o-Y Growth Trend Analysis By Function, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Function, 2023 to 2033 8. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Distribution Channel, 2018 to 2022 8.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Distribution Channel, 2023 to 2033 8.3.1. Hypermarket/ Supermarket 8.3.2. Specialty Stores 8.3.3. E-Commerce 8.3.4. Pharmacy Stores 8.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2018 to 2022 8.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023 to 2033 9. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By End User 9.1. Introduction / Key Findings 9.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By End User, 2018 to 2022 9.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By End User, 2023 to 2033 9.3.1. Women 9.3.2. Seniors 9.3.3. Kids 9.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022 9.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 10. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Introduction 10.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Country, 2018 to 2022 10.3. Current Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Country, 2023 to 2033 10.3.1. UK 10.3.2. Germany 10.3.3. Italy 10.3.4. France 10.3.5. Spain 10.3.6. Rest of Western Europe 10.4. Market Attractiveness Analysis By Country 11. UK Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region 11.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Region 11.2.1.1. England 11.2.1.2. Scotland 11.2.1.3. Wales 11.2.1.4. Northern Ireland 11.2.2. By Bacteria 11.2.3. By Form 11.2.4. By Function 11.2.5. By Distribution Channel 11.2.6. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Region 11.3.2. By Bacteria 11.3.3. By Form 11.3.4. By Function 11.3.5. By Distribution Channel 11.3.6. By End User 11.4. Key Takeaways 12. Germany Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region 12.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Region 12.2.1.1. North-east (Germany) 12.2.1.2. North-west (Germany) 12.2.1.3. Central (Germany) 12.2.1.4. South (Germany) 12.2.1.5. Other(Germany) 12.2.2. By Bacteria 12.2.3. By Form 12.2.4. By Function 12.2.5. By Distribution Channel 12.2.6. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Region 12.3.2. By Bacteria 12.3.3. By Form 12.3.4. By Function 12.3.5. By Distribution Channel 12.3.6. By End User 12.4. Key Takeaways 13. Italy Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region 13.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Region 13.2.1.1. North (Italy) 13.2.1.2. Central (Italy) 13.2.1.3. South (Italy) 13.2.1.4. Islands (Italy) 13.2.2. By Bacteria 13.2.3. By Form 13.2.4. By Function 13.2.5. By Distribution Channel 13.2.6. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Region 13.3.2. By Bacteria 13.3.3. By Form 13.3.4. By Function 13.3.5. By Distribution Channel 13.3.6. By End User 13.4. Key Takeaways 14. France Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region 14.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Region 14.2.1.1. Northern (France) 14.2.1.2. Central (France) 14.2.1.3. Southern (France) 14.2.1.4. Eastern (France) 14.2.2. By Bacteria 14.2.3. By Form 14.2.4. By Function 14.2.5. By Distribution Channel 14.2.6. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Region 14.3.2. By Bacteria 14.3.3. By Form 14.3.4. By Function 14.3.5. By Distribution Channel 14.3.6. By End User 14.4. Key Takeaways 15. Spain Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region 15.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Region 15.2.1.1. Basque Country 15.2.1.2. Andalusia 15.2.1.3. Extremadura 15.2.1.4. Catalonia 15.2.1.5. Valencia 15.2.1.6. Rest of Spain 15.2.2. By Bacteria 15.2.3. By Form 15.2.4. By Function 15.2.5. By Distribution Channel 15.2.6. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Region 15.3.2. By Bacteria 15.3.3. By Form 15.3.4. By Function 15.3.5. By Distribution Channel 15.3.6. By End User 15.4. Key Takeaways 16. Rest of Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033 16.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022 16.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033 16.2.1. By Bacteria 16.2.2. By Form 16.2.3. By Function 16.2.4. By Distribution Channel 16.2.5. By End User 16.3. Market Attractiveness Analysis 16.3.1. By Bacteria 16.3.2. By Form 16.3.3. By Function 16.3.4. By Distribution Channel 16.3.5. By End User 16.4. Key Takeaways 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Bacteria 17.3.3. By Form 17.3.4. By Function 17.3.5. By Distribution Channel 17.3.6. By End User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Bio-Kult 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.1.5.2. Product Strategy 18.1.1.5.3. Channel Strategy 18.1.2. Optibac Probiotics 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.2.5.2. Product Strategy 18.1.2.5.3. Channel Strategy 18.1.3. Symprove 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.3.5.2. Product Strategy 18.1.3.5.3. Channel Strategy 18.1.4. ProVen Probiotics 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.4.5.2. Product Strategy 18.1.4.5.3. Channel Strategy 18.1.5. Sanofi. 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.5.5.2. Product Strategy 18.1.5.5.3. Channel Strategy 18.1.6. Jarrow Formulas 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.6.5.2. Product Strategy 18.1.6.5.3. Channel Strategy 18.1.7. NOVA Probiotics 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.7.5.2. Product Strategy 18.1.7.5.3. Channel Strategy 18.1.8. Lifeway Foods 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.8.5.2. Product Strategy 18.1.8.5.3. Channel Strategy 18.1.9. Total Nutrition, Inc. 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.9.5.2. Product Strategy 18.1.9.5.3. Channel Strategy 18.1.10. Pharma Care Laboratories 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.10.5.2. Product Strategy 18.1.10.5.3. Channel Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Food and Beverage Insights
View Reports
Demand and Trend Analysis of Probiotic Supplement in Western Europe
